18620-02-5

Basic information

• Product Name: Magnesium, bromo(4-bromophenyl)-
• Synonyms: Magnesium, bromo(4-bromophenyl)-;4-Bromophenylmagnesium bromide, 0.50 M in THF;4-Bromophenylmagnesium bromide, 0.50 M in 2-MeTHF;4-Bromophenylmagnesium bromide
• CAS NO: 18620-02-5
• Molecular Formula: C₆H₄Br₂Mg
• Molecular Weight: 260.23
• Mol File: 18620-02-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Magnesium, bromo(4-bromophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Magnesium, bromo(4-bromophenyl)-(18620-02-5)
• EPA Substance Registry System: Magnesium, bromo(4-bromophenyl)-(18620-02-5)

Safety Data

• Hazardous Substances Data: 18620-02-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Magnesium, bromo(4-bromophenyl)is used as a reagent in organic synthesis for its ability to facilitate the formation of new chemical compounds. Its unique properties make it a valuable component in the creation of a wide range of organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Magnesium, bromo(4-bromophenyl)is used as a brominating agent for the synthesis of various organic compounds. Its application is crucial in the development of new drugs and the modification of existing ones to enhance their efficacy and safety.
Used in Flame Retardant Production:
Magnesium, bromo(4-bromophenyl)is utilized in the production of flame retardants, which are essential in preventing the spread of fire in various materials and products. Its brominating properties contribute to the effectiveness of these fire safety compounds.
Used in Dye Production:
This chemical compound is also used in the production of dyes, where its brominating capabilities aid in the synthesis of a variety of colorants used in different industries, including textiles, plastics, and printing.
Used in Other Industrial Chemicals:
Beyond the mentioned applications, Magnesium, bromo(4-bromophenyl)is employed in the synthesis of other industrial chemicals, highlighting its versatility and importance in various chemical processes.

Upstream product

• 106-37-6 1.4-dibromobenzene 
• 7439-95-4 magnesium 
• 2043-10-9 chloro-chloromethyl-dimethylsilane 
• 1719-57-9 Chloro(chloromethyl)dimethylsilane 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 4654-39-1 4-bromophenethanol 
• 61592-47-0 1-(4-bromophenyl)-2-chloroethan-1-ol 
• 100124-17-2 (4-bromo-phenyl)-[4]pyridyl ketone-imine 
• 106-40-1 4-bromo-aniline 
• 856099-40-6 5-(4-bromo-phenyl)-5-hydroxy-1-methyl-pyrrolidin-2-one 
• 100794-27-2 3-(4-bromo-phenyl)-1-butyl-pyrrolidin-3-ol 
• 2159-40-2 2-(4-bromobenzoyl)benzoic acid 
• 6999-03-7 1-bromo-4-(trimethylsilyl)benzene 
• 1585-07-5 1-bromo-4-ethylbenzene 
• 61623-62-9 1-(p-bromophenyl)-1,1-diphenylcarbinol 
• 2039-82-9 1-bromo-4-ethenyl-benzene 
• 18089-97-9 bis-(4-bromo-phenyl)-chloro-methyl-silane 
• 18141-19-0 (4-bromophenyl)(dichloro)(methyl)silane 
• 30314-45-5 1-(4-bromophenyl)-2,2-dimethylpropan-1-one 

Relevant articles and documents

Fluorene-containing organic compound and application thereof on OLED (organic light emitting diode) device

The invention discloses a fluorene-containing organic compound and an application thereof on an OLED (organic light emitting diode) device. The organic compound has the structure shown in the generalformula (1). The compound has higher glass transition temperature and molecular heat stability, proper HOMO and LUMO energy levels and higher Eg, the photoelectric property of an OLED device can be effectively improved and the service life of the OLED device can be effectively prolonged through structure optimization of the device.

PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS

The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitors of the complement alternative pathway, in particular of Factor B. The present invention further p

Copper-catalyzed difluoromethylation of β,γ-unsaturated carboxylic acids: An efficient allylic difluoromethylation

Not one but two! A new strategy for the regiospecific construction of compounds with allylic CF2H groups has been developed. The decarboxylative (phenylsulfonyl)difluoromethylation of β,γ- unsaturated carboxylic acids is catalyzed by a Lewis acid (CuCl 2·2 H2O), and the resulting product easily undergoes desulfonylation. Copyright

Process For Production Of 4-Biphenylyazetidin-2-Ones

The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula

Anti-hypercholesterolemic biaryl azetidinone compounds

This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts thereof, wherein R12 is an alkyl, alkeny or alkynyl group mono- or poly-substituted with —OH, —COOH or a combination of —OH and —COOH, and R9 contains an alkyl, alkeny or alkynyl group substituted with a heterocyclic ring, amino or sulfonyl. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating atherosclerosis and preventing atherosclerotic disease events.

Novel Piperidine Carboxylic Acid Amide Derivatives

The invention relates to novel piperidine carboxylic acid amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of these

BISANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME

A bisanthracene derivative having a specific structure in which two anthracene groups are bonded via a bonding group composed of naphthylene group and p-phenylene group, and an organic electroluminescence device having an organic thin film layer, which ha

Novel Thiophene Derivatives as Spingosine-1-Phosphate-1 Receptor Agonists

The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.

PHENYLAZETIDINONE DERIVATIVES

Various azetidinone derivatives are described, as are pharmaceutical compositions containing these compounds and methods of treatment of diseases using these compounds. Other embodiments are also described.

ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS

The invention relates to chemical genera of organometal benzenephosphonates useful in cross-coupling organic synthesis, having general formula (I): where R is selected from boron, zinc, tin and silicon residues.